What is Polymerase Chain Reaction Technologies?
Polymerase chain reaction (PCR) is an efficient and cost-effective molecular tool to copy or amplify small pieces of DNA in order to generate thousands to millions of copies of a DNA sequence. PCR technology combines the principles of harmonizing nucleic acid hybridization with those of nucleic acid replication that are applied constantly through numerous cycles. Several advanced techniques have been testified on sample dispersion, thermal cycling and output monitoring of digital PCR. PCR amplification produces the substantial amounts of DNA that is essential for molecular and genetic analysis. Variations of the technology are accessible to support PCR testing, which comprises thermal cyclers, gradient PCR machines, PCR workstations and cabinets, and qPCR machines.
The market study is broken down by Type (Real-time PCR, Traditional PCR and Digital PCR), by Application (Genetic Fingerprinting, Identification of Infectious Agents, Detection of Mutation, Cloning Genes and PCR Sequencing) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Polymerase Chain Reaction Technologies market throughout the predicted period.
Thermo Fisher Scientific Inc. (United States), Takara Bio Inc. (Japan), Fluidigm Corporation (United States), F. Hoffmann-LA Roche AG (ROCHE) (Switzerland), Bio-Rad Laboratories, Inc. (United States), Agilent Technologies, Inc. (United States), Biomerieux S.A. (France), LGC Limited (United Kingdom), Qiagen N.V. (Germant), Beckman Coulter (United States), Becton, Dickinson and Company (United States), Eppendorf (Germany), GE Healthcare (United States), Promega (United States) and Siemens Healthcare (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Fluidigm (United States) and Affymetrix Inc. (United States).
AdvanceMarketAnalytics has segmented the market of Global Polymerase Chain Reaction Technologies market by Type, Application and Region.
On the basis of geography, the market of Polymerase Chain Reaction Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Product Type, the sub-segment i.e. Reagents & Consumables will boost the Polymerase Chain Reaction Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-Use, the sub-segment i.e. Diagnostic Centers & Hospitals will boost the Polymerase Chain Reaction Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
The FDA regulates commercial DNA amplification-based in vitro diagnostic kits used to detect human diseases in clinical laboratories. Although FDA regulatory standards have not been developed for PCR diagnostic kits, a "Guidance Document" has been prepared by FDA's Center for Devices and Radiological Health. This document provides general guidance to manufacturers concerning the information needed by the FDA for evaluating applications for in vitro diagnostic devices intended to detect microorganisms in human specimens using nucleic acid amplification methods.
- Emphasizing On Development of Portable and Compact PCR Devices
- Technological Advancement in the PCR Devices
- Growing Prevalence of Genetic Disorders
- Government Initiatives for Human Genome Project
- Increasing Demand for Plant Derived To Genome-Based Drug Discovery
- Rising Healthcare Infrastructure in the Developing Economies
- High Cost Associated With Digital PCR and Real-Time PCR
Key Target AudienceManufacturers of PCR Devices, Suppliers of PCR Devices, PCR Service Providers, Healthcare Industry, Regulatory Bodies and Others
About ApproachDuring this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase